Skip to main content
. Author manuscript; available in PMC: 2010 Mar 5.
Published in final edited form as: Mol Cell Endocrinol. 2008 Nov 5;300(1-2):115–120. doi: 10.1016/j.mce.2008.10.032

Figure 4.

Figure 4

Western immunoblot of aromatase (CYP19) protein in an aldosterone-producing adrenal adenoma, a feminizing estrogen-secreting adrenal carcinoma and H295 cells after treatment (12 h) with VIP (100 nM) or forskolin (10 μM). Lane 1: Aldosterone-producing adrenal adenoma (15 μg protein); lane 2: Estrogen-secreting adrenal carcinoma (15 μg protein); lane 3: Untreated control H295 cells (15 μg protein); lane 4: Forskolin (Fsk)-treated H95 cells (15 μg protein); lane 5: VIP-treated H295 cells (15 μg protein).